logo
EN 简
Company Introduction

Belief BioMed Group (BBM) was founded in September 2016, is a leading innovative pharmaceutical company that combines gene therapy drug R&D, manufacturing platforms and clinical transformation. The Company established offices，R&D centers and manufacturing in China Shanghai, Beijing, Suzhou, Hong Kong and North Carolina. BBM is committed to providing innovative therapies for single gene disorder diseases, neurodegenerative diseases and malignant diseases through adeno-associated virus (AAV) vector technology.

5000

m2 Production and Research Base

300

m2 Non-human Primate Experiment Center

15000

m2 GMP Production Facility

Science & Pipeline

In the deepest despair, you will see the most beautiful stars of hope

Scientific Platform
Manufacturing
Diseases
Pipeline
Recent News
Belief BioMed Completed Dosing of the First Subject in the Registrational Gene Therapy Clinical Trial for Hemophilia B

2021-12-30

Remarkable success once more! Belief BioMed won the award of "the 10th China Innovation and Entrepreneurship Competition Excellent Enterprise"

2021-11-29

2021 Future Medical Industry Summit, Dr. Xiao xiao【Gene Therapy: Expansion from Rare Disease to Common Medicine】

2021-10-11

Belief Biomed’s Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China

2021-08-10

Belief BioMed and China Chord Rare Disease Center held a meeting in Minhang, Shanghai

2021-02-02

Belief BioMed announced the opening of new development & manufacturing center in Minhang Shanghai

2020-10-18

Investor Relations
Click to Enter arrow
Careers

We are looking for colleagues who own the common values and goals to create the bright future of BBM and benefit the patients.

We are dedicated to building a working environment that keeps our team inspired and valued. 

Click to Enter arrow